Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin

BACKGROUND: Doxorubicin, an anthracycline chemotherapeutic agent, is widely used in the treatment of many cancers. However, doxorubicin posts a great risk of adverse cardiovascular events, which are thought to be caused by oxidative stress. We recently reported that the ubiquitin E3 ligase TRIM21 in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:EBioMedicine
Egile Nagusiak: Hou, Kai, Shen, Jianliang, Yan, Junrong, Zhai, Chuannan, Zhang, Jingxia, Pan, Ji-An, Zhang, Ye, Jiang, Yaping, Wang, Yongbo, Lin, Richard Z., Cong, Hongliang, Gao, Shenglan, Zong, Wei-Xing
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2021
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8261003/
https://ncbi.nlm.nih.gov/pubmed/34233258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2021.103456
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak